Loading...
My burning issues in the neoadjuvant treatment for breast cancer
A combination of anthracyclines and taxanes remains the standard of care for neoadjuvant chemotherapy (NACT) resulting in increased breast conservation rate (BCR) and decreased recurrence rate [1]. Whether pathological complete response (pCR) could be an appropriate surrogate parameter for long-term...
Saved in:
| Published in: | Memo |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Springer Vienna
2017
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5862920/ https://ncbi.nlm.nih.gov/pubmed/29606978 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12254-017-0378-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|